Guus de Wilde

3PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 02, 2022
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity.

Timon A Bloedjes, Guus de Wilde, Gerarda H Khan

|Jan 26, 2021
Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma.

Timon A Bloedjes, Guus de Wilde, Jeroen E J Guikema

|Jul 28, 2019
The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors.

Mahnoush Bahjat, Guus de Wilde, Tijmen van Dam

Pageof 1